Herbal medicine for pneumoconiosis: a phase 2 trial
Part of Lungs & breathing clinical trials.
This study tests a modified Chinese herbal formula (Qing-Zao-Jiu-Fei Decoction) to see if it helps people with pneumoconiosis, a lung disease caused by inhaling dust. You would take the herbal medicine and have regular check-ups to see how your lungs respond.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 85 years old.
- You have been officially diagnosed with pneumoconiosis (a type of lung disease from dust exposure).
- You are willing to have blood tests, fill out questionnaires, and take the study medication as directed.
- You are not regularly taking other Chinese herbal medicines now or in the last 2 weeks.
- You do not have other serious lung or heart diseases, or a history of cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program that helps people with pneumoconiosis (a lung disease from dust exposure) build healthy habits. It may provide support to improve your quality of life.
This Phase 3 trial tests whether pirfenidone slows or improves lung damage in people with silicosis or coal worker’s pneumoconiosis. It looks at both effectiveness and side effects, and uses lung function tests and lung scans to track changes over time.
This study is building a long-term group of people with pneumoconiosis to better understand the disease and how dust exposure affects health. It does not involve any new treatments or medicines.
This trial tests a traditional Chinese herbal compound formula for people with COPD. It aims to see if the herbal treatment can help improve lung health when used on top of standard inhaler therapy.
This trial tests if adding a Chinese herbal formula (BaiDiZiYin ShenQiYiFei) to standard tuberculosis drugs helps improve symptoms like shortness of breath, fatigue, and coughing. It may be helpful for people diagnosed with pulmonary TB who also have signs of Qi and Yin deficiency (a traditional Chinese medicine pattern).
This trial tests a combination of traditional Chinese and Western medicine for adults with severe pneumonia caused by bacteria that are resistant to multiple antibiotics. It aims to see if this combined approach can improve treatment outcomes.
Hear when a new Pneumoconiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.